Immunoglobulin gene analysis in chronic lymphocytic leukemia in the era of next generation sequencing
…, PM Kolijn, PJ Hengeveld, A Chatzidimitriou… - Leukemia, 2020 - nature.com
Twenty years after landmark publications, there is a consensus that the somatic hypermutation
(SHM) status of the clonotypic immunoglobulin heavy variable (IGHV) gene is an …
(SHM) status of the clonotypic immunoglobulin heavy variable (IGHV) gene is an …
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
A Agathangelidis, A Chatzidimitriou… - Blood, The Journal …, 2021 - ashpublications.org
Chronic lymphocytic leukemia (CLL) is characterized by the existence of subsets of patients
with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …
with (quasi)identical, stereotyped B-cell receptor (BcR) immunoglobulins. Patients in certain …
[HTML][HTML] T cells in chronic lymphocytic leukemia: a two-edged sword
…, K Stamatopoulos, A Chatzidimitriou - Frontiers in …, 2021 - frontiersin.org
Chronic lymphocytic leukemia (CLL) is a malignancy of mature, antigen-experienced B
lymphocytes. Despite great progress recently achieved in the management of CLL, the disease …
lymphocytes. Despite great progress recently achieved in the management of CLL, the disease …
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on …
A Agathangelidis, A Chatzidimitriou… - Leukemia, 2022 - nature.com
The somatic hypermutation (SHM) status of the clonotypic immunoglobulin heavy variable (IGHV)
gene is a critical biomarker for assessing the prognosis of patients with chronic …
gene is a critical biomarker for assessing the prognosis of patients with chronic …
Detecting SARS-CoV-2 lineages and mutational load in municipal wastewater and a use-case in the metropolitan area of Thessaloniki, Greece
…, S Laidou, E Vlachonikola, A Chatzidimitriou… - Scientific reports, 2022 - nature.com
The COVID-19 pandemic represents an unprecedented global crisis necessitating novel
approaches for, amongst others, early detection of emerging variants relating to the evolution …
approaches for, amongst others, early detection of emerging variants relating to the evolution …
N-Glycosylation of the Ig Receptors Shapes the Antigen Reactivity in Chronic Lymphocytic Leukemia Subset #201
…, A Agathangelidis, A Chatzidimitriou… - The Journal of …, 2023 - journals.aai.org
Subset #201 is a clinically indolent subgroup of patients with chronic lymphocytic leukemia
defined by the expression of stereotyped, mutated IGHV4-34/IGLV1-44 BCR Ig. Subset #201 …
defined by the expression of stereotyped, mutated IGHV4-34/IGLV1-44 BCR Ig. Subset #201 …
[HTML][HTML] High-Throughput immunogenetics for precision medicine in cancer
…, F Davi, AW Langerak, A Chatzidimitriou - Seminars in cancer …, 2022 - Elsevier
Cancer is characterized by an extremely complex biological background, which hinders
personalized therapeutic interventions. Precision medicine promises to overcome this obstacle …
personalized therapeutic interventions. Precision medicine promises to overcome this obstacle …
Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169
…, M Degano, A Chatzidimitriou - Blood, The Journal …, 2021 - ashpublications.org
Chronic lymphocytic leukemia (CLL) major stereotyped subset 2 (IGHV3-21/IGLV3-21, ∼2.5%
of all cases of CLL) is an aggressive disease variant, irrespective of the somatic …
of all cases of CLL) is an aggressive disease variant, irrespective of the somatic …
[HTML][HTML] B cell receptor immunogenetics in B cell lymphomas: immunoglobulin genes as key to ontogeny and clinical decision making
…, E Sofou, M Papaioannou, A Chatzidimitriou… - Frontiers in …, 2020 - frontiersin.org
The clonotypic B cell receptor immunoglobulin (BcR IG) plays a seminal role in B cell lymphoma
development and evolution. From a clinical perspective, this view is supported by the …
development and evolution. From a clinical perspective, this view is supported by the …
Chromatin activation profiling of stereotyped chronic lymphocytic leukemias reveals a subset 8–specific signature
…, N Stavroyianni, A Chatzidimitriou… - Blood, The Journal …, 2023 - ashpublications.org
The chromatin activation landscape of chronic lymphocytic leukemia (CLL) with stereotyped
B-cell receptor immunoglobulin is currently unknown. In this study, we report the results of a …
B-cell receptor immunoglobulin is currently unknown. In this study, we report the results of a …
